Aetna: Payer announces it will pay for fluoro with injections

Why This Topic Matters

It helps readers understand a payer-level change affecting claims processing for interventional pain and related injection services, and why monitoring carrier policies and society advocacy matters for reimbursement workflows.

Article Sections

1. Policy change and effective date

   Introduces the payer update and the date on which the new reimbursement approach is said to begin. It frames the issue as a claims-processing and payment-policy change for relevant services.

2. Background on bundling edits and payer response

   Summarizes the broader payer-edit issue that led to bundled claims handling and notes that some payers continued those practices. It also places the update in the context of prior policy changes.

3. Specialty-society advocacy and carrier reactions

   Describes the response from physician organizations and how those groups engaged with insurers. It also references related carrier discussions and physician efforts to seek policy changes.

4. Aetna's clarification

   Explains the payer’s stated scope for separate reimbursement and the circumstances noted by the company. The section focuses on the scope of the policy change rather than detailed coding application.

5. Practical carrier-appeal approach and resources

   Discusses the general approach practices were encouraged to take when dealing with denials and references supporting society materials. It closes with resource pointers for readers seeking the underlying correspondence.